Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Jill R. Dietz, MD, is a staff physician in the Department of Breast Services at Cleveland Clinic's main campus. She was appointed in 2007 after having served more than five years as an assistant professor, Department of General Surgery, Washington University School of Medicine, St. Louis, Mo. Dr. Dietz is board-certified by the American Board of Surgery and National Board of Medical Examiners.
Dr. Dietz received her medical degree from Jefferson Medical College of Thomas Jefferson University, Philadelphia, Penn. She completed a residency in general surgery at Cleveland Clinic and a fellowship in breast surgery at the Cleveland Clinic Breast Center.
She was named one of Cleveland’s “Best Doctors” in Cleveland Magazine three years in a row. Dr. Dietz is a fellow of the American College of Surgeons and member of several professional organizations, including the American Society of Breast Surgeons and Society of Surgical Oncology. She is a contributing editor for the Women’s Oncology Review and is a reviewer for other peer-reviewed journals. A researcher and teacher, Dr. Dietz is among other things Program Director for the surgical breast fellowship at Cleveland Clinic.
Breast cancer, breast diagnostics, breast diseases, breast surgical oncology, minimally invasive breast surgery, oncoplastic surgery, high risk breast cancer and prevention, intraoperative radiation, placement of balloon catheter for partial breast radiation, cryoablation of the breast for benign tumors
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/18/2013, Dr. Dietz has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.